Fred Hutchinson Cancer Research Center
Cures Start Here.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
A Postdoctoral Research Fellow position is available for a qualified scientist to join the laboratories of Dr. Marie Bleakley and Dr. Jim Olson at the Fred Hutchinson Cancer Research Center.
The post-doctoral research fellow will work collaborative projects in the Bleakley and Olson Labs primarily on laboratory studies including, but not limited to, cancer antigen discovery, molecular cloning and evaluation of T cell receptors (TCRs) and transgene constructs
patient derived-xenograft models.
The successful applicant will employ strategies such as functional T cell assays, cell culture, multi-parametric flow cytometry, flow sorting, DNA extraction for TCR sequencing, analysis of TCR sequencing data, isolation of cancer-specific T cells from human peripheral blood, experimentation in patient-derived xenografts, quantitative PCR and bioinformatics analysis.
Applicants will have a PhD in a biological science and/or a MD. The ideal candidate will have a research background in immunology with robust skills in molecular and cellular biology, including flow cytometry, T cell functional assays, DNA and RNA extraction, molecular cloning, PCR and quantitative PCR. Desirable skills include bioinformatics analysis, scientific writing and presentations.
To be successful in this position, the post-doctoral research fellow must be highly motivated with a track record of productive research, exemplified by first author publication(s) and presentations, and willing to work in a highly collaborative, fast paced, collaborative and dynamic environment. This position is suited to someone who enjoys mastering new skills, multitasking and working in a multiple team environment.
This is a full-time position with a salary based on the NIH scale and excellent benefits.
We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at (see application details) or by calling (see application details).
Fred Hutchinson Cancer Research Center
Website : https://www.fredhutch.org/en.html
About Fred Hutchinson Cancer Research Center Arnold Building and Vessel sculpture on the Hutchinson Center campus The Arnold Building and Vessel sculpture sit at the heart of the Hutchinson Center campus. At Fred Hutch, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit of, and passion for, health knowledge and hope to their work and the world. Together, our researchers are discovering new ways to detect cancers earlier, when cure rates are highest; developing effective treatments with fewer side effects; and learning how to prevent cancers from growing in the first place. Our groundbreaking discoveries began in the 1970s with Dr. E. Donnall Thomas’s pioneering work in bone marrow transplantation, which led to him receiving the 1990 Nobel Prize in physiology or medicine. Since then, Hutch researchers have made a number of breakthroughs, including developing immunotherapies that use the immune system to defeat cancer and advancing the understanding of human biology. Admittedly, the eradication of cancer and other life-threatening diseases is an ambitious goal, one that demands tenacity, scientific excellence, collaboration and breakthrough creativity. To accomplish this, Fred Hutch attracts some of the world's greatest minds. Nobel laureate medal Dr. E. Donnall Thomas won the 1990 Nobel Prize for physiology or medicine for pioneering bone marrow transplantation. Our roster of internationally acclaimed scientists includes a MacArthur fellow, seven members of the National Academy of Sciences, five members of the Institute of Medicine, six members of the American Academy of Arts and Sciences, nine members of the American Association for the Advancement of Science and eight current and former Howard Hughes Medical Institute investigators. Fred Hutch understands that disease research means more than searching for new treatments. We are home to the country's largest and oldest cancer prevention program, which has made key contributions to understanding how diet, exercise and other factors reduce the risk of acquiring the disease. To accelerate our progress, we are part of the Fred Hutch / University of Washington Cancer Consortium. This research and clinical collaboration between the Hutch, the University of Washington, Seattle Children’s and Seattle Cancer Care Alliance enables our researchers to leverage each institution’s strengths and develop premier research programs across many types of disease. The Consortium is among 45 National Cancer Institute-designated comprehensive cancer centers nationwide.